И. С. Стилиди

660 total citations
103 papers, 372 citations indexed

About

И. С. Стилиди is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, И. С. Стилиди has authored 103 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 46 papers in Oncology and 31 papers in Surgery. Recurrent topics in И. С. Стилиди's work include Gastric Cancer Management and Outcomes (24 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). И. С. Стилиди is often cited by papers focused on Gastric Cancer Management and Outcomes (24 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). И. С. Стилиди collaborates with scholars based in Russia, Indonesia and United States. И. С. Стилиди's co-authors include Н. Е. Кушлинский, Давид Заридзе, Е. С. Герштейн, А. Д. Каприн, M. Smans, О. В. Ковалева, Alexei Gratchev, В. Б. Матвеев, A. Tryakin and Е. А. Короткова and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

И. С. Стилиди

74 papers receiving 351 citations

Peers

И. С. Стилиди
Seiji Hoshi Japan
Masaru Ishida Japan
Tetsuya Urasaki Japan
Masao Kataoka Japan
Oktay Bozkurt Türkiye
Shuai Hu China
Tomohiro Funakoshi United States
Nae Yu Kim South Korea
Masayuki Okido Japan
Seiji Hoshi Japan
И. С. Стилиди
Citations per year, relative to И. С. Стилиди И. С. Стилиди (= 1×) peers Seiji Hoshi

Countries citing papers authored by И. С. Стилиди

Since Specialization
Citations

This map shows the geographic impact of И. С. Стилиди's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. С. Стилиди with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. С. Стилиди more than expected).

Fields of papers citing papers by И. С. Стилиди

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by И. С. Стилиди. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. С. Стилиди. The network helps show where И. С. Стилиди may publish in the future.

Co-authorship network of co-authors of И. С. Стилиди

This figure shows the co-authorship network connecting the top 25 collaborators of И. С. Стилиди. A scholar is included among the top collaborators of И. С. Стилиди based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. С. Стилиди. И. С. Стилиди is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ковалева, О. В., et al.. (2025). Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications. Biomedicines. 13(2). 500–500. 4 indexed citations
2.
3.
4.
Кушлинский, Н. Е., et al.. (2024). The content of soluble forms of galectins -1, -3, -4, -7, -9 in patients with renal cell cancer of various morphological types. SHILAP Revista de lepidopterología. 52(3). 107–119.
5.
Стилиди, И. С., et al.. (2024). Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data. SHILAP Revista de lepidopterología. 26(2). 202–209. 1 indexed citations
6.
Poddubnaya, I V, et al.. (2023). Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study. SHILAP Revista de lepidopterología. 25(2). 208–213. 1 indexed citations
7.
Tryakin, A., et al.. (2023). The results of treatment for resectable gastric cancer with microsatellite instability. 13(2). 17–26. 3 indexed citations
8.
Короткова, Е. А., et al.. (2023). Galectin-3 and matrix metalloproteinases 2 and 9 in peripheral blood of gastric cancer patients. SHILAP Revista de lepidopterología. 51(1). 23–31. 1 indexed citations
9.
Ковалева, О. В., et al.. (2022). DIAGNOSTIC AND PROGNOSTIC POTENTIAL OF THE RESIDENT NON-SMALL CELL LUNG CANCER MICROBIOME. Russian Clinical Laboratory Diagnostics. 67(8). 458–462. 4 indexed citations
10.
Логинов, В. И., И. В. Пронина, Е. А. Филиппова, et al.. (2022). Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases. International Journal of Molecular Sciences. 23(3). 1300–1300. 19 indexed citations
11.
Ковалева, О. В., et al.. (2022). Prognostic significance of sPD-1/sPD-L1 in renal cancer depending on the phenotype of tumor and stromal cells. Cancer Urology. 18(2). 17–28. 1 indexed citations
12.
Стилиди, И. С., et al.. (2022). The Correlation of Ten Immune Checkpoint Gene Expressions and Their Association with Gastric Cancer Development. International Journal of Molecular Sciences. 23(22). 13846–13846. 8 indexed citations
13.
Бредер, В. В., et al.. (2022). Second line drug therapy for biliary cancer. Meditsinskiy sovet = Medical Council. 136–147.
14.
Кушлинский, Н. Е., et al.. (2021). Prognostic significance of soluble forms of immune checkpoint PD-1/PDL1 receptor and ligand in blood plasma of gastric cancer patients. Russian Clinical Laboratory Diagnostics. 66(3). 139–146. 6 indexed citations
15.
Ворохобина, Н. В., et al.. (2021). Study of urine steroid profiles by gas chromatography-mass spectrometry in patients with adrenocortical cancer in the course of treatment. Almanac of Clinical Medicine. 49(4). 277–284. 1 indexed citations
16.
Стилиди, И. С., et al.. (2021). Metastatic gastrointestinal stromal tumor of the greater omentum. Case report. SHILAP Revista de lepidopterología. 23(4). 680–684.
17.
18.
Герштейн, Е. С., et al.. (2020). SOLUBLE FORMS OF PD-1 AND PD-L1 IN BLOOD PLASMA OF GASTRIC CANCER PATIENTS AND THEIR ASSOCIATIONS WITH CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF THE DISEASE. Russian Clinical Laboratory Diagnostics. 65(6). 347–352. 6 indexed citations
19.
Mochalova, Anastasia, et al.. (2019). Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia. SHILAP Revista de lepidopterología. 104–113. 1 indexed citations
20.
Melnichenko, G. А., et al.. (2014). Draft of Russian Guidelines of Diagnosis and Treatment of Adrenal Cortical Cancer. SHILAP Revista de lepidopterología.  (1). 4–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiji Hoshi Breakdown of academic impact, for papers by Masaru Ishida Breakdown of academic impact, for papers by Tetsuya Urasaki Breakdown of academic impact, for papers by Masao Kataoka Breakdown of academic impact, for papers by Oktay Bozkurt Breakdown of academic impact, for papers by Shuai Hu Breakdown of academic impact, for papers by Tomohiro Funakoshi Breakdown of academic impact, for papers by Nae Yu Kim Breakdown of academic impact, for papers by Masayuki Okido
Rankless by CCL
2026